Victor J. Dzau, president of the National Academy of Medicine, has been elected to a second six-year term, beginning in July. In addition, Carlos del Rio, executive associate dean for Emory University School of Medicine at Grady Health System, has been elected as the next foreign secretary of the National Academy of Medicine.
In a unanimous vote, the FDA Oncologic Drugs Advisory Committee advised the agency to accept the metric of “minimal residual disease,” or MRD, as a basis for accelerated approvals of therapies in all settings of multiple myeloma.
